Literature DB >> 6330239

Biologic and biophysical markers of a live varicella vaccine strain (Oka): identification of clinical isolates from vaccine recipients.

Y Hayakawa, S Torigoe, K Shiraki, K Yamanishi, M Takahashi.   

Abstract

Possible biologic and biophysical markers of the Oka vaccine strain of varicella-zoster virus (VZV) were explored. The ratio between the infectivity of the vaccine strain in guinea-pig embryo fibroblasts and that in human embryo fibroblasts was consistently higher than the corresponding ratios for wild-type strains; this result seemed to correlate with the passage history of the vaccine strain in guinea-pig embryo fibroblasts. According to profiles of cleavage of digested DNA by various restriction endonucleases, the mobility of one fragment (K) produced by restriction endonuclease Hpa I was unique to the Oka strain. Nine clinical isolates from vaccine recipients (seven with varicella and two with zoster) were examined by both methods (infectivity and cleavage profiles) to determine whether or not these strains were vaccine derived. The laboratory judgments obtained by the two methods were in agreement and were consistent with clinical conclusions concerning five of the strains. Since the test of relative infectivity is simple and convenient, it is suitable for differentiation of the vaccine strain from other wild-type strains; if the results are not conclusive, profiles of cleavage by Hpa I may be helpful in reaching a definite judgment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330239     DOI: 10.1093/infdis/149.6.956

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination.

Authors:  Winsome Barrett Muir; Richard Nichols; Judith Breuer
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Variable R1 region in varicella zoster virus in fulminant type of acute retinal necrosis syndrome.

Authors:  T Abe; M Sato; M Tamai
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

3.  Varicella-zoster vaccine virus: evolution in action.

Authors:  Jeffrey I Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-21       Impact factor: 11.205

4.  Variation of R1 repeated sequence present in open reading frame 11 of varicella-zoster virus strains.

Authors:  H Kinoshita; R Hondo; F Taguchi; Y Yogo
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

5.  Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates.

Authors:  W Soong; J C Schultz; A C Patera; M H Sommer; J I Cohen
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Vaccination to prevent varicella and shingles.

Authors:  J Breuer
Journal:  J Clin Pathol       Date:  2001-10       Impact factor: 3.411

7.  Varicella-zoster virus infection induces autophagy in both cultured cells and human skin vesicles.

Authors:  Marie-Noëlle Takahashi; Wallen Jackson; Donna T Laird; Timothy D Culp; Charles Grose; John I Haynes; Luca Benetti
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  Identification of varicella-zoster virus strains by PCR analysis of three repeat elements and a PstI-site-less region.

Authors:  M Takada; T Suzutani; I Yoshida; M Matoba; M Azuma
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

9.  Reactogenicity to a live attenuated varicella vaccine in Canadian children.

Authors:  F Diaz-Mitoma; S A Halperin; D Scheifele
Journal:  Can J Infect Dis       Date:  2000-03

10.  Strain variation of R5 direct repeats in the right-hand portion of the long unique segment of varicella-zoster virus DNA.

Authors:  R Hondo; Y Yogo
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.